Cereno Scientific announces new Executive Management Team
Cereno Scientific (Nasdaq First North: CRNO B) today announced that they have expanded the Executive Management Team to include the newly appointed Chief Medical Officer & Head of Research & Development, Rahul Agrawal, and the Business Development Director, Julia Fransson, to strengthen focus on the strategic priorities in development programs of lead candidate drug CS1 in PAH, and CS014 in thrombosis prevention and CS585 in not yet decided cardiovascular indication.The Executive Management Team now includes: · Chief Executive Officer (CEO) – Sten R. Sörensen · Chief Scientific